Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:45:49.062Z.
Calculation as of: 2026-10-06T19:45:49.062Z.
Quote observation: 2026-10-06T19:45:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c4088ee3877f0fa8fb1d478ebd945bbdf3f6f56484e99899685bc9bfb173ee48
PE RATIO
N/A
PE RATIO AVG TTM
1.58
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$3.83M
PE Ratio
N/A
TTM Avg
8.63
3Y Avg
8.63
5Y Avg
8.63
Market Cap
$4.27M
PE Ratio
N/A
TTM Avg
79.42
3Y Avg
79.42
5Y Avg
79.42
Market Cap
$3.60M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.64M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.98M | N/A | 1.58 | N/A | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | N/A | N/A | N/A | N/A |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.83M | N/A | 8.63 | 8.63 | 8.63 |
| GRI Bio, Inc. (GRI)vs › | $4.27M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.27M | N/A | 79.42 | 79.42 | 79.42 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.60M | N/A | N/A | N/A | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.64M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.59M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.33M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.62M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$1.82
Forward EPS (Est.)
$-17.04
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2023-08-10 | 0.12 |
| 2023-08-09 | 0.13 |
| 2023-08-08 | 0.13 |
| 2023-08-07 | 0.14 |
| 2023-08-04 | 0.16 |
| 2023-08-03 | 0.16 |
| 2023-08-02 | 0.16 |
| 2023-08-01 | 0.26 |
| 2023-07-31 | 0.28 |
| 2023-07-28 | 0.27 |
| 2023-07-27 | 0.28 |
| 2023-07-26 | 0.27 |
| 2023-07-25 | 0.28 |
| 2023-07-24 | 0.30 |
| 2023-07-21 | 0.28 |
| 2023-07-20 | 0.28 |
| 2023-07-19 | 0.24 |
| 2023-07-18 | 0.29 |
| 2023-07-17 | 0.38 |
| 2023-07-14 | 0.40 |
| 2023-07-13 | 0.42 |
| 2023-07-12 | 0.43 |
| 2023-07-11 | 0.47 |
| 2023-07-10 | 0.46 |
| 2023-07-07 | 0.41 |
| 2023-07-06 | 0.39 |
| 2023-07-05 | 0.39 |
| 2023-07-03 | 0.38 |
| 2023-06-30 | 0.39 |
| 2023-06-29 | 0.39 |
| 2023-06-28 | 0.38 |
| 2023-06-27 | 0.37 |
| 2023-06-26 | 0.36 |
| 2023-06-23 | 0.36 |
| 2023-06-22 | 0.38 |
| 2023-06-21 | 0.40 |
| 2023-06-20 | 0.41 |
| 2023-06-16 | 0.40 |
| 2023-06-15 | 0.43 |
| 2023-06-14 | 0.42 |
| 2023-06-13 | 0.43 |
| 2023-06-12 | 0.42 |
| 2023-06-09 | 0.42 |
| 2023-06-08 | 0.43 |
| 2023-06-07 | 0.44 |
| 2023-06-06 | 0.42 |
| 2023-06-05 | 0.43 |
| 2023-06-02 | 0.43 |
| 2023-06-01 | 0.42 |
| 2023-05-31 | 0.42 |
| 2023-05-30 | 0.43 |
| 2023-05-26 | 0.44 |
| 2023-05-25 | 0.43 |
| 2023-05-24 | 0.45 |
| 2023-05-23 | 0.48 |
| 2023-05-22 | 0.46 |
| 2023-05-19 | 0.45 |
| 2023-05-18 | 0.45 |
| 2023-05-17 | 0.45 |
| 2023-05-16 | 0.43 |
| 2023-05-15 | 0.44 |
| 2023-05-12 | 0.43 |
| 2023-05-11 | 0.94 |
| 2023-05-10 | 0.96 |
| 2023-05-09 | 0.93 |
| 2023-05-08 | 0.94 |
| 2023-05-05 | 0.96 |
| 2023-05-04 | 0.96 |
| 2023-05-03 | 0.98 |
| 2023-05-02 | 0.96 |
| 2023-05-01 | 1.01 |
| 2023-04-28 | 1.07 |
| 2023-04-27 | 1.10 |
| 2023-04-26 | 1.06 |
| 2023-04-25 | 1.12 |
| 2023-04-24 | 0.92 |
| 2023-04-21 | 1.03 |
| 2023-04-20 | 1.02 |
| 2023-04-19 | 1.07 |
| 2023-04-18 | 1.05 |
| 2023-04-17 | 1.05 |
| 2023-04-14 | 1.06 |
| 2023-04-13 | 1.05 |
| 2023-04-12 | 1.02 |
| 2023-04-11 | 1.04 |
| 2023-04-10 | 0.98 |
| 2023-04-06 | 1.01 |
| 2023-04-05 | 1.02 |
| 2023-04-04 | 1.11 |
| 2023-04-03 | 1.16 |
| 2023-03-31 | 1.13 |
| 2023-03-30 | 1.65 |
| 2023-03-29 | 1.64 |
| 2023-03-28 | 1.53 |
| 2023-03-27 | 1.51 |
| 2023-03-24 | 1.50 |
| 2023-03-23 | 1.41 |
| 2023-03-22 | 1.50 |
| 2023-03-21 | 1.43 |
| 2023-03-20 | 1.43 |
| 2023-03-17 | 1.43 |
| 2023-03-16 | 1.47 |
| 2023-03-15 | 1.47 |
| 2023-03-14 | 1.51 |
| 2023-03-13 | 1.51 |
| 2023-03-10 | 1.51 |
| 2023-03-09 | 1.61 |
| 2023-03-08 | 1.66 |
| 2023-03-07 | 1.74 |
| 2023-03-06 | 1.75 |
| 2023-03-03 | 1.74 |
| 2023-03-02 | 1.70 |
| 2023-03-01 | 1.70 |
| 2023-02-28 | 1.72 |
| 2023-02-27 | 1.68 |
| 2023-02-24 | 1.63 |
| 2023-02-23 | 1.72 |
| 2023-02-22 | 1.72 |
| 2023-02-21 | 1.67 |
| 2023-02-17 | 1.61 |
| 2023-02-16 | 1.61 |
| 2023-02-15 | 1.66 |
| 2023-02-14 | 1.66 |
| 2023-02-13 | 1.64 |
| 2023-02-10 | 1.71 |
| 2023-02-09 | 1.62 |
| 2023-02-08 | 1.64 |
| 2023-02-07 | 1.77 |
| 2023-02-06 | 1.73 |
| 2023-02-03 | 1.73 |
| 2023-02-02 | 1.78 |
| 2023-02-01 | 1.78 |
| 2023-01-31 | 1.86 |
| 2023-01-30 | 1.85 |
| 2023-01-27 | 1.94 |
| 2023-01-26 | 1.93 |
| 2023-01-25 | 1.94 |
| 2023-01-24 | 1.94 |
| 2023-01-23 | 1.98 |
| 2023-01-20 | 1.94 |
| 2023-01-19 | 2.06 |
| 2023-01-18 | 1.75 |
| 2023-01-17 | 1.82 |
| 2023-01-13 | 1.82 |
| 2023-01-12 | 1.88 |
| 2023-01-11 | 1.86 |
| 2023-01-10 | 1.85 |
| 2023-01-09 | 1.88 |
| 2023-01-06 | 1.77 |
| 2023-01-05 | 1.82 |
| 2023-01-04 | 1.89 |
| 2023-01-03 | 1.85 |
| 2022-12-30 | 1.88 |
| 2022-12-29 | 1.85 |
| 2022-12-28 | 1.70 |
| 2022-12-27 | 1.65 |
| 2022-12-23 | 1.68 |
| 2022-12-22 | 1.70 |
| 2022-12-21 | 1.68 |
| 2022-12-20 | 1.68 |
| 2022-12-19 | 1.62 |
| 2022-12-16 | 1.75 |
| 2022-12-15 | 1.82 |
| 2022-12-14 | 2.04 |
| 2022-12-13 | 2.31 |
| 2022-12-12 | 3.17 |
| 2022-12-09 | 2.81 |
| 2022-12-08 | 2.82 |
| 2022-12-07 | 2.70 |
| 2022-12-06 | 2.63 |
| 2022-12-05 | 2.55 |
| 2022-12-02 | 2.51 |
| 2022-12-01 | 2.50 |
| 2022-11-30 | 2.53 |
| 2022-11-29 | 2.49 |
| 2022-11-28 | 2.34 |
| 2022-11-25 | 2.36 |
| 2022-11-23 | 2.40 |
| 2022-11-22 | 2.37 |
| 2022-11-21 | 2.33 |
| 2022-11-18 | 2.53 |
| 2022-11-17 | 2.51 |
| 2022-11-16 | 2.52 |
| 2022-11-15 | 2.71 |
| 2022-11-14 | 2.61 |
| 2022-11-11 | 2.55 |
| 2022-11-10 | 2.17 |
| 2022-11-09 | 2.12 |
| 2022-11-08 | 2.17 |
| 2022-11-07 | 2.19 |
| 2022-11-04 | 2.20 |
| 2022-11-03 | 2.32 |
| 2022-11-02 | 2.33 |
| 2022-11-01 | 2.30 |
| 2022-10-31 | 2.31 |
| 2022-10-28 | 2.29 |
| 2022-10-27 | 2.29 |
| 2022-10-26 | 2.27 |
| 2022-10-25 | 2.16 |
| 2022-10-24 | 2.11 |
| 2022-10-21 | 2.18 |
| 2022-10-20 | 2.04 |
| 2022-10-19 | 2.15 |
| 2022-10-18 | 2.22 |
| 2022-10-17 | 2.25 |
| 2022-10-14 | 2.17 |
| 2022-10-13 | 2.29 |
| 2022-10-12 | 2.26 |
| 2022-10-11 | 2.22 |
| 2022-10-10 | 2.23 |
| 2022-10-07 | 2.25 |
| 2022-10-06 | 2.40 |
| 2022-10-05 | 2.36 |
| 2022-10-04 | 2.30 |
| 2022-10-03 | 2.23 |
| 2022-09-30 | 2.33 |
| 2022-09-29 | 2.26 |
| 2022-09-28 | 2.48 |
| 2022-09-27 | 2.30 |
| 2022-09-26 | 2.39 |
| 2022-09-23 | 2.39 |
| 2022-09-22 | 2.52 |
| 2022-09-21 | 2.60 |
| 2022-09-20 | 2.63 |
| 2022-09-19 | 2.79 |
| 2022-09-16 | 2.74 |
| 2022-09-15 | 2.86 |
| 2022-09-14 | 2.83 |
| 2022-09-13 | 2.98 |
| 2022-09-12 | 2.80 |
| 2022-09-09 | 2.93 |
| 2022-09-08 | 2.86 |
| 2022-09-07 | 2.73 |
| 2022-09-06 | 2.69 |
| 2022-09-02 | 2.73 |
| 2022-09-01 | 2.75 |
| 2022-08-31 | 2.71 |
| 2022-08-30 | 2.70 |
| 2022-08-29 | 2.75 |
| 2022-08-26 | 2.77 |
| 2022-08-25 | 2.84 |
| 2022-08-24 | 2.83 |
| 2022-08-23 | 2.79 |
| 2022-08-22 | 2.72 |
| 2022-08-19 | 2.63 |
| 2022-08-18 | 3.01 |
| 2022-08-17 | 2.96 |
| 2022-08-16 | 3.32 |
| 2022-08-15 | 3.51 |
| 2022-08-12 | 3.38 |
